Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study

Digestive and Liver Disease

Volumn 39, Issue 4, 2007, Pages 329-337

  Biancone, L ^a   Gionchetti, P ^b   Blanco, G Del Vecchio ^a   Orlando, A ^c   Annese, V ^d   Papi, C ^e   Sostegni, R ^f   D'Inca R ^g   Petruzziello, C ^a   Casa, A ^c   Sica, G ^a   Calabrese, E ^a   Campieri, M ^b   Pallone, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

^f MAURIZIANO HOSPITAL   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

Distal ulcerative colitis; Double blind study; Mesalazine; Topical beclomethasone diproprionate

Indexed keywords

BECLOMETASONE DIPROPIONATE; ENEMA; MESALAZINE; TOPSTER; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTEROPATHY; FEMALE; FOAM; GASTROINTESTINAL ENDOSCOPY; HEMATOCHEZIA; HOSPITAL DEPARTMENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT REFERRAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; REMISSION; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; STUDENT T TEST; TREATMENT OUTCOME; ULCERATIVE COLITIS; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; COLITIS, ULCERATIVE; COLONOSCOPY; DIARRHEA; DOUBLE-BLIND METHOD; ENEMA; FEMALE; HUMANS; MALE; MESALAMINE; MIDDLE AGED; OCCULT BLOOD; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33947227795     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.01.012     Document Type: Article

References (36)

1. Truelove S.C. Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium. A report on a controlled therapeutic trial. Br Med J 2 (1958) 1072-1077
2. Truelove S.C. Systemic and local corticosteroids therapy in ulcerative colitis. Br Med J 1 (1960) 464-467
3. McDougal L. Treatment of ulcerative colitis with rectal steroids. Lancet (1963) 1826-1827
4. Lee D., Taylor G.M., James V.H.T., and Walker G. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut 20 (1979) 349-355
5. Cann P.A., and Holdsworth C.D. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet i (1987) 922-923
6. Brattsand R. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can J Gastroenterol 4 (1990) 407-419
7. Geier D.L., and Miner P.B. New therapeutic agents in the treatment of inflammatory bowel disease. Am J Med 93 (1992) 199-208
8. Brogden R.N., Heel R.C., and Speight T.M. Beclomethasone dipropionate: a reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 28 (1984) 99-126
9. Busse W.W. What role for inhaled steroids in chronic asthma?. Chest 104 (1993) 1565-1571
10. Kumana C.R., Seaton T., Meghhji M., Castelli M., Benson R., and Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producting Cushing's sindrome or hypothalamic pituitary adrenal suppression. Lancet 1 (1982) 579-583
11. Bansky G., Buhler H., Stamm B., Hacki W.H., Buchmann P., and Muller J. Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side-effects. Dis Colon Rectum 30 (1987) 288-292
12. Levine D.S., Raisys V.A., and Ainardi V. Coating of oral beclomethasone dipropionate capsules with cellulose acetate phtalate enhances delivery of topically active antiinflammatory drug to terminal ileum. Gastroenterology 92 (1987) 1037-1044
13. Halpern Z., Sold O., Baratz M., Konikoff F., Halak A., and Gilat T. A controlled trial of beclomethasone versus beclomethasone enemas in distal ulcerative colitis. J Clin Gastroenterol 13 (1991) 38-41
14. Campieri M., Cottone M., Miglio F., Manenti F., Astegiano M., D'Arienzo A., et al. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther 12 (1998) 361-366
15. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis proctosigmoiditis and proctitis. Gastroenterology 92 (1987) 1894-1898
16. Mulder C.J., Fockens P., Mejier J.W., van der Heide H., Wiltink E.H., and Tytgat G.N. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Eur J Gastroenterol Hepatol 8 (1996) 549-553
17. Gionchetti P., D'Arienzo A., Rizzello F., Magnuso F., Maieron R., Lecis P.E., et al., Italian BDP Study Group. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalazine: a single-blind randomized controlled trial. J Clin Gastroenterol 39 (2005) 291-297
18. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298 (1989) 82-86
19. Truelove S.C., and Richards W.C.D. Biopsy studies in ulcerative colitis. BMJ 1 (1956) 1315-1318
20. Campieri M. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Gut 50 (2002) 43-46
21. Campieri M., Adamo S., Valpiani D., D'Arienzo A., D'Albasio G., Pitzalis M., et al. Oral beclomethasone dipropionate in the treatment of estensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther 17 (2003) 1471-1480
22. Rizzello F., Giochetti P., D'Arienzo A., Manguso F., Di Matteo G., Annese V., et al. Oral beclomethasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 16 (2002) 1109-1116
23. Dahlstrom K., Edsbacker S., and Kallen A. Rectal pharmacokinetics of budesonide. Eur J Clin Gastroenterol 4 (1990) 415-416
24. Lofberg R., Thomsen O., Langholz E., Schioler R., Danielsson A., Suhr O., et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 8 (1994) 623-629
25. Rutgeerts P. Budesonide enemas for topical therapy of ulcerative colitis. Can J Gastroenterol 4 (1990) 415-416
26. Hanauer S.B., Robinson M., Pruitt R., Lazenby A.J., Persson T., Nilsson L.G., et al. Budesonide enema for the treatment of active distal Ulcerative Colitis and proctitis: a dose-ranging study. Gastroenterology 115 (1998) 525-532
27. Marteau P., Probert C.S., Lindgren S., Gassul M., Tan T.G., Dignass A., et al. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double-blind, placebo controlled study. Gut 54 (2005) 960-965
28. Campieri M., Corbelli C., Gionchetti P., Brignola C., Belluzzi A., DiFebo G., et al. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Dig Dis Sci 37 (1992) 1890-1897
29. Campieri M., Paoluzi P., D'Albasio G., Brunetti G., Pera A., and Barbara L. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. Dig Dis Sci 38 (1993) 1843-1850
30. Ardizzone S., Doldo P., Ranzi T., Sturniolo G.C., Giglio L.A., Annese V., et al. Mesalazine for (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol 31 (1999) 677-684
31. Hammond A., Andus T., Gierend M., Ecker K.W., Sholmerich J., Herfarth H., and German Budesonide Foam Study Group. Hepatogastroenterology 51 (2004) 1345-1349
32. Tarpila S., Turunen U., Seppala K., Aukee S., Pikkarainen P., Elomaa I., et al. Budesonide enema in active haemorragic proctitis-a controlled trial against hydrocortisone foam enema. Aliment Pharmacol Ther 8 (1994) 591-595
33. Ruddell W.S., Dickinson R.J., Dixon M.F., and Axon A.T. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 21 (1980) 885-889
34. Paoluzi P., D'Albasio G., Pera A., Bianchi Porro G., Paoluzi O.A., Pica R., et al. Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis 34 (2002) 787-793
35. Klotz U. Colonic targeting of aminosalicylates for the treatment of ulcerative colitis. Dig Liv Dis 37 (2005) 381-388
36. Bitton A., and Peppercorn M.A. Medical therapy of ulcerative proctitis and proctosigmoiditis, including refractory disease. Inflamm Bowel Dis 1 (1995) 207-219